Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
TATTON: a multi-arm, phase Ib trial of osimertinib combin... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer
0
Authors
Geoffrey Oxnard
14 more
Geoffrey Oxnard
•
J.C.-H. Yang
12 more
•
Myung‐Ju Ahn
Published
March 2, 2020
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Annals of Oncology
Topics
Medicine
Cancer Oncology
Internal Medicine
Gastroenterology
Pulmonary And Respiratory Medicine
Show all topics
DOI
10.1016/j.annonc.2020.01.013
License
publisher-specific-oa
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Annals of Oncology
Topics
Medicine
Cancer Oncology
Internal Medicine
Gastroenterology
Pulmonary And Respiratory Medicine
Show all topics
DOI
10.1016/j.annonc.2020.01.013
License
publisher-specific-oa
